We report a 29-year-old black male with cutis verticis gyrata, folliculitis decalvans and folliculitis keloidalis nuchae confirmed by biopsy. He had been using dreadlocks for 5 years before the appearance of the lesions. An activation of the different fibroblast growth factor members may explain the development of hyperproliferation of collagen, fibrosis and keloid lesions. We suggest a hypothesis of a common pathogenesis for the three conditions in a genetically predisposed patient. Inflammation and traction caused by the dreadlocks can act as a possible trigger factor.

1.
Larsen F, Birchall N: Cutis verticis gyrata: three cases with different etiologies that demonstrate the classification system. Australas J Dermatol 2007;48:91-94.
2.
Ross EK, Tan E, Shapiro J: Update on primary cicatricial alopecias. J Am Acad Dermatol 2005;53:1-35.
3.
Luz Ramos M, Muñoz-Pérez MA, Pons A, Ortega M, Camacho F: Acne keloidalis nuchae and tufted hair folliculitis. Dermatology 1997;194:71-73.
4.
Filosto M, Tonin P, Vattemi G, Bongiovanni LG, Rizzuto N, Tomelleri G: Cutis verticis gyrata, mental retardation and Lennox-Gastaut syndrome: a case report. Neurol Sci 2001;22:253-256.
5.
Pujol RM, García-Patos V, Ravella-Mateu A, Casanova JM, de Moragas JM: Tufted hair folliculitis: a specific disease? Br J Dermatol 1994;130:259-260.
6.
Fernandes JC, Correia TM, Azevedo F, Mesquita-Guimarães J: Tufted hair folliculitis after scalp injury. Cutis 2001;67:243-245.
7.
Powell JJ, Dawber RPR, Gatter K: Folliculitis decalvans including tufted folliculitis: clinical, histological and therapeutic findings. Br J Dermatol 1999;140:328-333.
8.
Chiarini C, Torchia D, Bianchi B, Volpi W, Caproni M, Fabbri P: Immunopathogenesis of folliculitis decalvans: clues in early lesions. Am J Clin Pathol 2008;130:526-534.
9.
Yan L, Cao R, Wang L, Liu Y, Pan B, Yin Y, Lv X, Zhuang Q, Sun X, Xiao R: Epithelial-mesenchymal transition in keloid tissues and TGF-β1-induced hair follicle outer root sheath keratinocytes. Wound Repair Regen 2015;23:601-610.
10.
Kanwar AJ, Ghosh S, Tami GP, Kaur S: Alopecia and cutis verticis gyrata due to traction presenting as headache. Int J Dermatol 1992;31:671-672.
11.
Khare AK, Singh G: Acquired cutis verticis gyrata due to rotational traction. Br J Dermatol 1984;110:125.
12.
Kanwar AJ, Kaur S: Some dermatoses peculiar to Sikh men. Int J Dermatol 1990;29:739-740.
13.
Harding JJ, et al: Cutis verticis gyrata in association with vemurafenib and whole-brain radiotherapy. J Clin Oncol 2014;32:e54-e56.
14.
Claude SB, Vaishali E: Dermal hypertrophies; in Jeffrey PC, Thomas DH, Anthony JM, Stuart JS, Julie VS, Thomas S, et al: Bolognia Dermatology. 2nd ed. Philadelphia, Mosby Elsevier, 2008, p 1502.
15.
Meyer KB, Maia AT, O'Reilly M, Teschendorff AE, Chin SF, Caldas C, et al: Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer. PLoS Biol 2008;6:e108.
16.
Yoo KH, Lee JW, Jang WS, Li K, Seo SJ, Hong CK: Cutis verticis gyrata and alopecia areata: a synchronous coincidence? Yonsei Med J 2010;51:612-614.
17.
Bianchi L, Lubrano C, Carrozzo AM, Iraci S, Tomassoli M, Spera G, Nini G: Pachydermoperiostosis: study of epidermal growth factor and steroid receptors. Br J Dermatol 1995;132:128-133.
18.
Tanus A, Oliveira CC, Villarreal DJ, Sanchez FA, Dias MF: Black women's hair: the main scalp dermatoses and aesthetic practices in women of African ethnicity. An Bras Dermatol 2015;90:450-465.
19.
Suchonwanit P, Hector CE, Bin Saif GA, McMichael AJ: Factors affecting the severity of central centrifugal cicatricial alopecia. Int J Dermatol 2016;55:338-343.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.